METCELA
Metcela is a clinical-stage biotech startup providing patients with an innovative and alternative treatment option for heart disease. The company's lead asset, MTC001 is a cell therapy based on VCAM-1-positive Cardiac Fibroblast (VCF) that re-established a favorable microenvironment and repaired damaged heart tissues in preclinical studies. Metcela's therapy uses a specific fibroblast cell that is obtained from the patient's heart and instead of replacing them, it repairs the damage by enhancing the cells' ability to heal, providing patients with an effective and reasonably-priced cure for heart failure. It was founded on March 9, 2016, and is headquartered in Kawasaki, Japan.
METCELA
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2016-03-09
Address:
Kawasaki, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.metcela.com
Total Employee:
11+
Status:
Active
Total Funding:
35.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
CEJ Fund
CEJ Fund investment in Series C - Metcela
Cyberdyne
Cyberdyne investment in Series C - Metcela
Reazon Holdings
Reazon Holdings investment in Series C - Metcela
Japan Lifeline
Japan Lifeline investment in Series C - Metcela
Sony Innovation Fund
Sony Innovation Fund investment in Series C - Metcela
Tsukuba Exceed Fund
Tsukuba Exceed Fund investment in Series B - Metcela
MAKOTO Capital
MAKOTO Capital investment in Series B - Metcela
Alfresa Holdings
Alfresa Holdings investment in Series B - Metcela
Sony Innovation Fund
Sony Innovation Fund investment in Series B - Metcela
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Metcela
Official Site Inspections
http://www.metcela.com Semrush global rank: 2.79 M Semrush visits lastest month: 5.82 K
- Host name: users306.vip.heteml.jp
- IP address: 157.7.44.181
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082